Be Ready to Handle Rxs for Direct Oral Anticoagulants for Cancer Patients

February 2019

Some patients with cancer will get a direct oral anticoagulant (DOAC), such as Xarelto or Lixiana, for a blood clot.

Patients with cancer tend to be at higher risk of blood clots compared to noncancer patients.

Injectable low-molecular-weight heparins (LMWH), such as dalteparin (Fragmin) or enoxaparin (Lovenox), are usually the go-to blood thinners to treat blood clots in patients with cancer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Medication Errors Stop Duplicate Therapy Errors in Their Tracks
Med Safety Prevent 2018's Top Med Safety Issues From Creeping Into 2019
Gastroenterology Look Out for Patients Picking Up More Than a Two-Week Supply of Nexium 24HR
Smoking Cessation Be Familiar With Smoking Cessation Meds for Patients With Cardiovascular Disease
Probiotics Watch for Patients Looking for Probiotics to Help a "Stomach Bug"
Anticoagulants Stay Alert for Patients Getting Two Oral Anticoagulants
Ear, Nose & Throat Listen for Patients Who Complain of Ringing in Their Ears
Adverse Events Steer Patients Concerned About Talc to the Pharmacist
Substance Use Disorder Sort Through Meds for Alcohol Use Disorder
Cancer Be Ready to Handle Rxs for Direct Oral Anticoagulants for Cancer Patients
Antibiotics Add Aorta Blood Vessel Ruptures to the List of Quinolone Concerns

Be Ready to Handle Rxs for Direct Oral Anticoagulants for Cancer Patients

Practical advice for a better career, with unlimited access to CE

Table of Contents